Transitioning Clinical Trial Patients to Commercial Supply via Managed Access Programs

This podcast describes how Managed Access Programs can continue treatment access for patients coming out of registration or other clinical trials who need to transition to commercial supply.

Thought Leaders:

Suzanne Gagnon, MD, Chief Medical Officer, Idis
Karen Searle PhD, Study Director, Neuroscience & General Medicine (NGM), Eisai Global Clinical Development
Michelle Gee, PhD, Director, Neuroscience & General Medicine (NGM), Eisai Global Clinical Development

Download Podcast

Download Podcast Transcript

Download related case study

See All PharmaVOICE Podcasts

See All PharmaVOICE White Papers

Continuing Access Post-Clinical Trial - Case Study

Clinical phases through launch

Download this free case study now.

Idis designed and implemented a Managed Access Program that enabled trial participants to continue use of the drug prior to its commercial availability, taking resource burden away from the company. Read this case study for more information, including the results of the program.

Provided by: Idis